Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26564569 | 1.00 | DNM1 (0.48) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL18177243 | 1.00 | DNM1 (0.48) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL26564568 | 1.00 | DNM1 (0.48) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL26564625 | 0.90 | ADRB2 (0.38) | DNM1TSHR | |
| SCHEMBL17793641 | 0.81 | DNM1 (0.37) | DNM1 | |
| SCHEMBL23733522 | 0.79 | DNM1 (0.47) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL9714467 | 0.79 | DNM1 (0.47) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL25762052 | 0.79 | DNM1 (0.47) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL9714381 | 0.79 | DNM1 (0.47) | DNM1THRBTSHRLPAR1LPAR3 | |
| SCHEMBL26564602 | 0.77 | PTPN7 (0.36) | MEN1KMT2AMAPTUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331657-A1 | NANOMATERIALS COMPRISING ESTER-LINKED ACETALS | BEAM THERAPEUTICS INC. | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331657-A1 | NANOMATERIALS COMPRISING ESTER-LINKED ACETALS | LIPA, SGMS1, SGMS2 | DNM1 3039/4885THRB 4343/4885TSHR 4628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.